China Resources Boya Bio pharmaceutical Group Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 26.98%

China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has an Asset Resilience Ratio of 26.98% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 300294 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥2.35 Billion

≈ $344.55 Million USD Cash + Short-term Investments

Total Assets

CN¥8.73 Billion

≈ $1.28 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how China Resources Boya Bio pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. See shareholders equity of China Resources Boya Bio pharmaceutical for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down China Resources Boya Bio pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of China Resources Boya Bio pharmaceutical .

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥2.35 Billion	26.98%
Total Liquid Assets	CN¥2.35 Billion	26.98%

Asset Resilience Insights

Very High Liquidity: China Resources Boya Bio pharmaceutical Group Co Ltd maintains exceptional liquid asset reserves at 26.98% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

China Resources Boya Bio pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare China Resources Boya Bio pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for China Resources Boya Bio pharmaceutical Group Co Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for China Resources Boya Bio pharmaceutical Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	26.18%	CN¥2.20 Billion ≈ $321.80 Million	CN¥8.40 Billion ≈ $1.23 Billion	-16.77pp
2023-12-31	42.95%	CN¥3.36 Billion ≈ $492.03 Million	CN¥7.83 Billion ≈ $1.15 Billion	+3.19pp
2022-12-31	39.76%	CN¥3.19 Billion ≈ $467.37 Million	CN¥8.03 Billion ≈ $1.18 Billion	+4.33pp
2021-12-31	35.42%	CN¥2.70 Billion ≈ $395.09 Million	CN¥7.62 Billion ≈ $1.12 Billion	+33.36pp
2016-12-31	2.07%	CN¥50.00 Million ≈ $7.32 Million	CN¥2.42 Billion ≈ $354.05 Million	+1.15pp
2015-12-31	0.91%	CN¥20.00 Million ≈ $2.93 Million	CN¥2.19 Billion ≈ $320.20 Million	--

pp = percentage points

About China Resources Boya Bio pharmaceutical Group Co Ltd

SHE:300294 China Biotechnology

Market Cap

$1.29 Billion

CN¥8.81 Billion CNY

Market Cap Rank

#8016 Global

#2011 in China

Share Price

CN¥17.48

Change (1 day)

-1.35%

52-Week Range

CN¥17.48 - CN¥27.67

All Time High

CN¥55.20